US Court to pharma giant Guardant Health: You willfully infringed patents for cancer-testing; asked to pay $245 million to University of Washington

A federal judge has finalized a judgment ordering pharma giant Guardant Health to pay more than $245 million to Seattle-based biotech startup TwinStrand Biosciences and the University of Washington for willfully infringing on patented DNA sequencing technology. The final order, entered in the U.S.

Raccontata damorningstar.cominvestors.combenzinga.comtimesofindia.indiatimes.com